5.3. Analysis.
Comparison 5 Rifampicin versus placebo or standard medication, Outcome 3 B) Subgroup analysis by control; SMD: pruritus on different scales; CP participants; cross‐over design.
Comparison 5 Rifampicin versus placebo or standard medication, Outcome 3 B) Subgroup analysis by control; SMD: pruritus on different scales; CP participants; cross‐over design.